Accessibility Menu

Abbott Makes It 359 in a Row

The medical device maker spun off its pharmaceuticals business to investors on January 1.

By Rich Duprey Sep 12, 2013 at 10:21PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.